CBLL.US CeriBell, Inc

Healthcare Health Care Equipment & Supplies USA Stocks
26.14 USD
Close of Nov 14, 2026
12.65 28.89
Market cap
USD 1.02B
P/E
-
P/B
8.72x
ROE
-68.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CBLL.US undervalued?

Graham number

The Graham number of CeriBell, Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CeriBell, Inc fundamental analysis

No fundamental analysis for CeriBell, Inc yet.

CeriBell, Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CeriBell, Inc

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In …

Full company profile